These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 5778911)
1. [Possibilities and limits of chemotherapy in the treatment of malignant lymphoma]. Gross R Strahlentherapie Sonderb; 1969; 69():75-94. PubMed ID: 5778911 [No Abstract] [Full Text] [Related]
2. [Study on antineoplastic chemotherapy of malignant lymphoma and the period of survival, with special reference to lymphatic reticulum cell sarcoma]. Sakai Y Naika; 1968 Sep; 22(3):651-61. PubMed ID: 4884751 [No Abstract] [Full Text] [Related]
3. [Therapy of hemoblastosis. IV. Malignant lymphomata]. Danieli G G Clin Med; 1967 Jan; 48(1):24-48. PubMed ID: 5604252 [No Abstract] [Full Text] [Related]
4. [Possibilities in the treatment of advanced malignant lymphoma insensitive to the usual combination of cytostatics]. Klener P; Donner L; Ort J Vnitr Lek; 1976 Aug; 22(8):760-6. PubMed ID: 61642 [No Abstract] [Full Text] [Related]
5. [The degree of malignancy of lymphomas and the adequacy of cytostatic treatment]. Zhuravlev VS Ter Arkh; 1994; 66(7):39-43. PubMed ID: 7985127 [No Abstract] [Full Text] [Related]
6. Combination chemotherapy in vitro. III. BCNU. Drewinko B; Loo TL; Freireich EJ Cancer Treat Rep; 1979 Mar; 63(3):373-5. PubMed ID: 427819 [No Abstract] [Full Text] [Related]
7. [Possibilities and limits of polychemotherapy in hematology]. István L Orv Hetil; 1982 Nov; 123(47):2879-85. PubMed ID: 7177635 [No Abstract] [Full Text] [Related]
8. Some clinical aspects of chemotherapy in malignant lymphomas. Ito Y Nagoya J Med Sci; 1967 Sep; 30(2):169-76. PubMed ID: 6081310 [No Abstract] [Full Text] [Related]
9. [Chemotherapy of malignant lymphoma]. Ota K; Oyama A Rinsho Hoshasen; 1973 Nov; 18(11):918-29. PubMed ID: 4797429 [No Abstract] [Full Text] [Related]
10. [Prognosis and therapy of non-Hodgkin's lymphoma in childhood]. Kühner U; Bleher EA; Gretillat P; Delalieu B; Pedrinis E; Wagner HP Monatsschr Kinderheilkd (1902); 1977 May; 125(5):461-2. PubMed ID: 876202 [No Abstract] [Full Text] [Related]
11. Hemostatic abnormalities and leukocyte activation caused by infection in patients with malignant lymphoma during chemotherapy. Kamikura Y; Wada H; Sase T; Yamaguchi M; Kaneko T; Sakaguchi A; Abe Y; Nishioka J; Nobori T; Shiku H Thromb Res; 2006; 117(6):671-9. PubMed ID: 16026816 [TBL] [Abstract][Full Text] [Related]
12. [Chemotherapy of malignant lymphoma]. Alberto P Cancro; 1973; 26(5):315-37. PubMed ID: 4793833 [No Abstract] [Full Text] [Related]
13. [Intermediate evaluation of a prospective study of the therapy of malignant non-Hodgkin lymphomas]. Jandl H; Franke A; Kammerer R; Spormann H Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(5):678-84. PubMed ID: 6172333 [No Abstract] [Full Text] [Related]
14. [Phase II study of mitoxantrone for hematologic malignancies]. Ueoka H; Ueno K; Yamane T; Toyoda K; Endo H; Nishihara R; Takahashi I; Ohnoshi T; Kitajima K; Kimura I Gan To Kagaku Ryoho; 1983 Nov; 10(11):2399-402. PubMed ID: 6639101 [TBL] [Abstract][Full Text] [Related]
15. [Advanced non-Hodgkin lymphomas in adults. Cytostatic chemotherapy]. Meuthen I; Mödder B Med Welt; 1981 Oct; 32(41):1545-7. PubMed ID: 7029199 [No Abstract] [Full Text] [Related]
16. Identification of patients at risk for early death after conventional chemotherapy in solid tumours and lymphomas. Ray-Coquard I; Ghesquière H; Bachelot T; Borg C; Biron P; Sebban C; LeCesne A; Chauvin F; Blay JY; Br J Cancer; 2001 Sep; 85(6):816-22. PubMed ID: 11556830 [TBL] [Abstract][Full Text] [Related]
17. [Superficial and deep lymph nodes: various responses to treatment in malignant lymphomas]. Morgenfeld MC; Helft F; Bomchil G Sangre (Barc); 1968; 13(3):313-9. PubMed ID: 5731168 [No Abstract] [Full Text] [Related]